Oishi K, Raynor R L, Charp P A, Kuo J F
Department of Pharmacology, Emory University School of Medicine, Atlanta, Georgia 30322.
J Biol Chem. 1988 May 15;263(14):6865-71.
Certain lysophospholipids, lysophosphatidylcholine (lyso-PC) in particular, stimulated protein kinase C at low concentrations (less than 20 microM) but, conversely, inhibited it at high concentrations (greater than 30 microM). Protein kinase C stimulation by lyso-PC required the presence of phosphatidylserine (PS) and Ca2+ and was associated with a decreased Ka for PS and increased Ka for Ca2+ of the enzyme. Cardiolipin and phosphatidic acid could partially substitute for PS in supporting the stimulatory effect of lyso-PC. Lyso-PC also biphasically regulated protein kinase C activated by diolein. Of several synthetic lyso-PC preparations tested, the oleoyl, myristoyl and palmitoyl derivatives were most active. Data from the Triton X-100 mixed micellar assay indicated that 1.4 and 14.0 mol of lyso-PC/micelle produced a maximal stimulation and a complete abolishment of the stimulation of protein kinase C, respectively. Protein kinase C stimulation by lyso-PC, with a pH optimum of about 7.5, was observed for phosphorylation of histone H1, myelin basic protein, and the 35- and 47-kDa proteins from the rat brain, but not for that of other histone subfractions and protamine. Lyso-PC acted synergistically with diacylglycerol in stimulating protein kinase C, whereas the stimulation by lyso-PC was additive to that by oleic acid. Protein kinase C inhibitors (alkyllysophospholipid, sphingosine, tamoxifen, and polymyxin B) inhibited more potently the protein kinase C activity stimulated by PS/Ca2+/lyso-PC than that stimulated by PS/Ca2+. The stimulatory and inhibitory effects of lyso-PC were not observed for myosin light chain kinase and cAMP-dependent protein kinase, indicating a specificity of its actions. The present findings suggested that lyso-PC, likely derived from membrane PC by the action of phospholipase A2, might play a role in signal transduction via a dual regulation of protein kinase C, and that it could further modulate the enzyme and hence the cellular activity by interplaying with diacylglycerol and unsaturated fatty acid, the two other classes of cellular mediators also shown to be activators of protein kinase C.
某些溶血磷脂,尤其是溶血磷脂酰胆碱(lyso-PC),在低浓度(小于20微摩尔)时刺激蛋白激酶C,但相反,在高浓度(大于30微摩尔)时抑制它。lyso-PC对蛋白激酶C的刺激需要磷脂酰丝氨酸(PS)和Ca2+的存在,并且与该酶对PS的Ka降低和对Ca2+的Ka增加有关。心磷脂和磷脂酸在支持lyso-PC的刺激作用方面可以部分替代PS。Lyso-PC也对由二油精激活的蛋白激酶C进行双相调节。在测试的几种合成lyso-PC制剂中,油酰基、肉豆蔻酰基和棕榈酰基衍生物活性最高。来自Triton X-100混合胶束测定的数据表明,每微胶束1.4和14.0摩尔的lyso-PC分别产生最大刺激和完全消除对蛋白激酶C的刺激。观察到lyso-PC对蛋白激酶C的刺激(最适pH约为7.5)可使组蛋白H1、髓鞘碱性蛋白以及大鼠脑内35 kDa和47 kDa蛋白发生磷酸化,但对其他组蛋白亚组分和鱼精蛋白则无此作用。Lyso-PC在刺激蛋白激酶C方面与二酰基甘油协同作用,而lyso-PC的刺激作用与油酸的刺激作用相加。蛋白激酶C抑制剂(烷基溶血磷脂、鞘氨醇、他莫昔芬和多粘菌素B)对PS/Ca2+/lyso-PC刺激的蛋白激酶C活性的抑制作用比对PS/Ca2+刺激的更有效。未观察到lyso-PC对肌球蛋白轻链激酶和cAMP依赖性蛋白激酶有刺激和抑制作用,表明其作用具有特异性。目前的研究结果表明,lyso-PC可能是由磷脂酶A2作用于膜磷脂酰胆碱产生的,可能通过对蛋白激酶C的双重调节在信号转导中发挥作用,并且它可以通过与二酰基甘油和不饱和脂肪酸相互作用进一步调节该酶,从而调节细胞活性,二酰基甘油和不饱和脂肪酸是另外两类也被证明是蛋白激酶C激活剂的细胞介质。